5386662025-10-012025-12-315386662025-04-012025-12-315386662025-10-012025-12-31in-capmkt:OtherExpenses1Member5386662025-10-012025-12-31in-capmkt:OtherExpenses2Member5386662025-04-012025-12-31in-capmkt:OtherExpenses1Member5386662025-04-012025-12-31in-capmkt:OtherExpenses2Member5386662025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15386662025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares538666SHARDACROPNOTLISTEDINE221J01015SHARDA CROPCHEM LIMITEDMain BoardEquity2025-04-012026-03-312026-01-292026-01-20INRLakhsQuarterlyThird quarterSingle segmentThe consolidated financial statements of the Company contains segment information as per IND AS 108 - Operating Segments accordingly separate information is not included in the Standalone financial results.2026-01-2912:45:002026-01-2914:00:00Not applicablefalsefalseNot applicable2025-10-012025-12-31UnauditedStandalone112105620007057960001191635800054758440002991554000-1172570000138115000661000832607000164710600099133170002003041000020030410001734960001574200003309160000167212500000001672125000109500016732200009022050001018.5318.530018.5318.53Quarterlyand nine months ended earnings per share is not annualised <BR> Notes: <BR> 1. The aforesaid financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on January 29, 2026. The statutory auditors have expressed an unmodified conclusion on these results. <BR> <BR> 2. The financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies Indian Accounting Standards Rules, 2015 as amended from time to time. <BR> <BR> <BR> 3. Other expenses income includes loss gain on fair valuation of investments as under: <BR> <BR> Particulars Quarter ended Nine months ended Year ended <BR> December 31, September 30, December 31, December 31, December 31, March 31 <BR> 2025 2025 2024 2025 2024 2025 <BR> Loss or gain on <BR> fair valuation of <BR> investments 182.25 -243.58 -418.09 -334.33 -1,092.72 -805.37 <BR> <BR> 4. Other income includes: <BR> <BR> Particulars Quarter ended Nine months ended Year ended <BR> December 31, September 30, Decemberr 31, December 31, December 31, March 31, <BR> 2025 2025 2024 2025 2024 2025 <BR> <BR> Dividend received <BR> from subsidiary 4,967.08 1,752.72 8,046.59 6,719.80 8,046.59 12,374.21 <BR> <BR> 5. One of the major segments of the Company, viz. Agrochemicals is seasonal in nature and its performance can be impacted by cropping pattern and weather conditions across the globe. Accordingly, quarterly figures are not representative of the other quarters and full year's performance. <BR> <BR> 6. The consolidated financial statements of the Company contains segment information as per IND AS 108 - Operating Segments accordingly separate information is not included in the Standalone financial results. <BR> <BR> 7.The Board of Directors at its meeting held on January 29, 2026 has declared an interim dividend Rs.6 /- per equity share. <BR> <BR> 8.On November 21, 2025, the Government of India notified the four labour codes, the code on Wages 2019, Industrial Relations Code 2020, Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code 2020 consolidating 29 existing labour laws. The Company has assessed and taken incremental impact of these changes on the basis of internal assessment with guidance provided by the Institute of Chartered Accountants of India. The incremental impact is not material. The Company continues to monitor the finalization of Central/State Rules and clarifications from the Government on other aspects of the Labour code and would provide appropriate accounting effect on the basis of such developments as needed. <BR> 2025-04-012025-12-31UnauditedStandalone27597417000148607300029083490000131435930008360664000-339794800036078200031360002374416000429291600025137559000394593100003945931000553522000143259000696781000032491500000000324915000016700032493170009022050001036.0136.010036.0136.01Other Expenses1612423000Foreign Exchange Gain or Loss34683000Other Expenses4858159000Foreign Exchange Gain or Loss-565243000Gratuity14650001465000Gratuity22300022300037000056000001095000167000